Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker TRAX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 3, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 13, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 13, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 22, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 14, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 5.01 Changes in Control of Registrant | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 3, 2026 | TRAX First Tracks Biotherapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances